Cite
HARVARD Citation
Gonczi, L. et al. (2017). Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort. Inflammatory bowel diseases. 23 (11), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gonczi, L. et al. (2017). Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort. Inflammatory bowel diseases. 23 (11), p. . [Online].